News stories about SeaSpine (NASDAQ:SPNE) have trended somewhat positive on Saturday, Accern Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. SeaSpine earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 46.9403879779094 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of equities analysts have recently issued reports on SPNE shares. HC Wainwright reiterated a “buy” rating and issued a $15.00 price objective on shares of SeaSpine in a report on Friday, November 3rd. Zacks Investment Research cut SeaSpine from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Ladenburg Thalmann Financial Services started coverage on SeaSpine in a report on Thursday, December 14th. They issued a “buy” rating and a $20.00 price objective for the company. Finally, BTIG Research reiterated a “buy” rating on shares of SeaSpine in a report on Monday, November 6th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company. SeaSpine currently has a consensus rating of “Buy” and an average price target of $17.25.

SeaSpine (SPNE) traded up $0.08 on Friday, hitting $10.22. The stock had a trading volume of 7,745 shares, compared to its average volume of 23,571. SeaSpine has a 1 year low of $6.31 and a 1 year high of $13.46. The stock has a market cap of $137.25 and a PE ratio of -3.51.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at

About SeaSpine

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Insider Buying and Selling by Quarter for SeaSpine (NASDAQ:SPNE)

Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with's FREE daily email newsletter.